BEUDAMED
    1,212 results · 23ms · Sources: EU EUDAMED, US FDA
    Filters Classification: FDA Class 2 ×

    Inherited Nucleotide Repeat Disorder Dna Test

    FDA classification
    FDA Class 2 ·Inherited Nucleotide Repeat Disorder Dna Test

    Nucleic Acid Amplification Test For The Quantitation Of Bk Virus (Bk) Dna

    FDA classification
    FDA Class 2 ·Nucleic Acid Amplification Test For The Quantitation Of Bk Virus (Bk) Dna

    Software, Similarity Score Algorithm, Tissue Of Origin For Malignant Tumor Types

    FDA classification
    FDA Class 2 ·Software, Similarity Score Algorithm, Tissue Of Origin For Malignant Tumor Types

    Respirator, Surgical

    FDA classification
    FDA Class 2 ·Respirator, Surgical

    Tonometer, Analyzer, Ocular Blood Flow

    FDA classification
    FDA Class 2 ·Tonometer, Analyzer, Ocular Blood Flow

    Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems

    FDA classification
    FDA Class 2 ·Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems

    Antigen, Invasive Fungal Pathogens

    FDA classification
    FDA Class 2 ·Antigen, Invasive Fungal Pathogens

    System, Microarray-Based, Genome-Wide, Postnatal Chromosomal Abnormality Detection

    FDA classification
    FDA Class 2 ·System, Microarray-Based, Genome-Wide, Postnatal Chromosomal Abnormality Detection

    Wound Dressing With Poly(Diallyl Dimethyl Ammonium Chloride)(Pdadmac)

    FDA classification
    FDA Class 2 ·Wound Dressing With Poly(Diallyl Dimethyl Ammonium Chloride)(Pdadmac)

    Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

    FDA classification
    FDA Class 2 ·Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

    Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings

    FDA classification
    FDA Class 2 ·Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings

    Simple In Vitro Diagnostic Device For The Detection Of Secreted Proteins From Bacillus Spp. In Human Clinical Samples

    FDA classification
    FDA Class 2 ·Simple In Vitro Diagnostic Device For The Detection Of Secreted Proteins From Bacillus Spp. In Human Clinical Samples